Skip to Main Content

Paper Details

Relationship between Tumor Mutational Burden, PD-L1, Patient Characteristics, and Response to Immune Checkpoint Inhibitors in Head and Neck Squamous Cell Carcinoma.
Cancers (Basel)
15
2021
HNSCC, Head and Neck Squamous Cell Carcinoma, PD-1, PD-L1, Patient, Patients, TMB, head and neck squamous cell cancer, laryngeal, patients, programmed death ligand-1, tumors
Author NameAffiliation
Umit TopalogluWake Forest Baptist Medical Center
Umit TopalogluWake Forest Baptist Medical Center
Ralph B D'AgostinoWake Forest Baptist Medical Center
  • 1 - 3

Datasets

Release 1.2